Variable | LDP (n = 86) | ODP (n = 86) | p value | LPD (n = 101) | OPD (n = 101) | p value |
---|---|---|---|---|---|---|
Operative time (min)a | 189.1 ± 45.2 | 213.3 ± 54.4 | < 0.01 | 416.2 ± 78.8 | 365.0 ± 81.6 | < 0.01 |
Estimated blood loss (mL)b | 180 (80–600) | 220 (120–800) | < 0.01 | 250 (150–900) | 300 (180–1000) | 0.04 |
RBC transfusion (%) | 3 (3.5%) | 10 (11.6%) | 0.04 | 14 (13.9%) | 22 (21.8%) | 0.14 |
Postoperative hospital stay (days)b | 9 (4–34) | 13 (7–42) | < 0.01 | 14 (9–69) | 18 (11–52) | < 0.01 |
Overall morbidity (n, %) | 8 (9.3%) | 14 (16.3%) | 0.17 | 22 (21.8%) | 32 (31.7%) | 0.11 |
CR-POPF | 5 | 7 | Â | 12 | 16 | Â |
DGE (Grade A/ Grade B, C) | 0 (0/0) | 3 (2/1) | Â | 6 (4/2) | 10 (5/5) | Â |
PPH (Grade A/ Grade B, C) | 0 (0/0) | 2 (1/1) | Â | 5 (1/4) | 6 (3/3) | Â |
Bile leak | 0 | 0 | Â | 2 | 3 | Â |
Wound infection | 0 | 2 | Â | 1 | 1 | Â |
Lymphorrhea | 1 | 0 | Â | 0 | 2 | Â |
Pulmonary complications | 2 | 2 | Â | 2 | 5 | Â |
Reoperation (%) | 0 | 0 | 1.00 | 6 (5.9%) | 8 (7.9%) | 0.58 |
Clavien-Dindo classification | Â | Â | 0.33 | Â | Â | 0.42 |
I-II | 4 (4.7%) | 5 (5.6%) | Â | 10 (9.9%) | 16 (15.8%) | Â |
III-IV | 4 (4.7%) | 9 (10.5%) | Â | 11 (10.9%) | 15 (14.9%) | Â |
V (90-day mortality) | 0 (0%) | 0 (0%) | Â | 1 (1.0%) | 1 (1.0%) | Â |
Adjuvant treatment (%) | 61 (70.9%) | 57 (66.3%) | 0.51 | 67 (66.3%) | 65 (64.4%) | 0.77 |
Time to adjuvant treatment (days)a | 50 (28–82) | 52 (26–88) | 0.14 | 59 (26–98) | 60 (26–103) | 0.68 |